John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$257M |
| 2 |
Boston Scientific
BSX
|
+$228M |
| 3 |
Meta Platforms (Facebook)
META
|
+$225M |
| 4 |
Amazon
AMZN
|
+$220M |
| 5 |
S&P Global
SPGI
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$252M |
| 2 |
PayPal
PYPL
|
+$252M |
| 3 |
Walt Disney
DIS
|
+$217M |
| 4 |
Chevron
CVX
|
+$206M |
| 5 |
Best Buy
BBY
|
+$152M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.83% |
| 2 | Consumer Discretionary | 13.53% |
| 3 | Financials | 9.1% |
| 4 | Healthcare | 9.07% |
| 5 | Consumer Staples | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Conduent
CNDT
$250M
| $8.85M | 0.03% |
1,842,742
+12,949
| +0.7% | +$54.1K |
|
652
Watsco Inc
WSO
$12.8B
| $8.83M | 0.03% |
38,960
+33,284
| +586% | +$7.65M |
|
653
Abercrombie & Fitch
ANF
$4.99B
| $8.82M | 0.03% |
433,211
+194,214
| +81% | +$3.56M |
|
654
PUT
Caterpillar
CAT
$373B
| $8.74M | 0.03% |
48,000
+38,200
| +390% | +$6.48M |
|
655
VICI Properties
VICI
$29.5B
| $8.72M | 0.03% |
342,058
-257,098
| -43% | -$6.38M |
|
656
Applied Materials
AMAT
$384B
| $8.7M | 0.03% |
+100,854
| New | +$7.45M |
|
657
iShares S&P 100 ETF
OEF
$20.2B
| $8.7M | 0.03% |
50,700
-3,600
| -7% | -$588K |
|
658
Allogene Therapeutics
ALLO
$701M
| $8.67M | 0.02% |
343,624
-21,024
| -6% | -$685K |
|
659
Amdocs
DOX
$6.48B
| $8.66M | 0.02% |
122,090
-14,162
| -10% | -$889K |
|
660
Transocean
RIG
$6.44B
| $8.65M | 0.02% |
3,746,700
+3,455,700
| +1,188% | +$5.08M |
|
|
CERN
661
DELISTED
Cerner Corp
CERN
| $8.54M | 0.02% |
108,748
+1,308
| +1% | +$96.9K |
|
662
CALL
Verizon
VZ
$208B
| $8.52M | 0.02% |
145,000
+48,500
| +50% | +$2.88M |
|
663
CALL
Merck
MRK
$372B
| $8.51M | 0.02% |
108,992
+66,548
| +157% | +$5.09M |
|
664
First Solar
FSLR
$22.4B
| $8.49M | 0.02% |
85,855
+18,624
| +28% | +$1.61M |
|
665
State Street Financial Select Sector SPDR ETF
XLF
$56.8B
| $8.49M | 0.02% |
287,905
-2,260,695
| -89% | -$60.5M |
|
666
CALL
Wayfair
W
$14.1B
| $8.47M | 0.02% |
37,500
+28,100
| +299% | +$7.46M |
|
667
Chipotle Mexican Grill
CMG
$48.1B
| $8.46M | 0.02% |
305,200
-302,200
| -50% | -$7.93M |
|
668
Madrigal Pharmaceuticals
MDGL
$11.8B
| $8.46M | 0.02% |
76,111
+9,489
| +14% | +$1.16M |
|
669
PUT
Royal Caribbean
RCL
$78.4B
| $8.44M | 0.02% |
113,000
-6,100
| -5% | -$425K |
|
670
Ultragenyx Pharmaceutical
RARE
$2.54B
| $8.35M | 0.02% |
60,312
+54,595
| +955% | +$6.48M |
|
671
CALL
Delta Air Lines
DAL
$54.2B
| $8.33M | 0.02% |
207,100
+101,200
| +96% | +$3.68M |
|
672
Tenet Healthcare
THC
$22.4B
| $8.29M | 0.02% |
+207,484
| New | +$6.7M |
|
673
CALL
Goldman Sachs
GS
$302B
| $8.23M | 0.02% |
31,200
+11,100
| +55% | +$2.47M |
|
674
Illinois Tool Works
ITW
$80.9B
| $8.21M | 0.02% |
40,285
+38,588
| +2,274% | +$7.89M |
|
675
CALL
Clorox
CLX
$13B
| $8.2M | 0.02% |
40,600
+36,200
| +823% | +$7.49M |
|
Similar funds
John Overdeck's Q4 2020 Portfolio in Review
As of Q4 2020, John Overdeck held 3,971 positions worth $34.9B, up 24% from $28.2B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.
John Overdeck deployed $1.95B of net new capital in Q4 2020, opening 955 new positions and adding to 1,167 existing holdings. Its largest new stake was Boston Scientific: 6,312,819 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Chevron, an estimated $206M trimmed.
- John Overdeck's largest Q4 2020 buy was Boston Scientific: 6,312,819 shares worth $227M.
- John Overdeck added most to NVIDIA in Q4 2020, an estimated $257M increase.
- John Overdeck's biggest Q4 2020 reduction was Chevron, cutting an estimated $206M.
- John Overdeck fully exited Pfizer in Q4 2020, selling an estimated $252M.
- John Overdeck's ten largest holdings make up 7.4% of its $34.9B portfolio in Q4 2020.
- John Overdeck opened 955 new positions and closed 694 in Q4 2020.
- John Overdeck's portfolio value rose 24% quarter-over-quarter to $34.9B.
Based on Two Sigma Investments's 13F filing for Q4 2020, filed 16 Feb 2021.